Loading...
XNASSDGR
Market cap1.44bUSD
Dec 24, Last price  
19.73USD
1D
-0.15%
1Q
7.00%
IPO
-38.19%
Name

Schrodinger Inc

Chart & Performance

D1W1MN
XNAS:SDGR chart
P/E
35.27
P/S
6.63
EPS
0.56
Div Yield, %
0.00%
Shrs. gr., 5y
9.12%
Rev. gr., 5y
26.59%
Revenues
217m
+19.73%
55,693,00066,639,00085,543,000108,095,000137,931,000180,955,000216,666,000
Net income
41m
P
-17,392,000-28,425,000-25,681,000-26,637,000-101,219,000-149,189,00040,720,000
CFO
-137m
L+14.25%
-15,307,000-23,711,000-26,059,00016,757,000-70,669,000-119,683,000-136,733,000
Earnings
Feb 26, 2025

Profile

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
URL
https://www.schrodinger.com
IPO date
Feb 06, 2020
Employees
787
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
216,666
19.73%
180,955
31.19%
137,931
27.60%
Cost of revenue
394,114
327,772
249,374
Unusual Expense (Income)
NOPBT
(177,448)
(146,817)
(111,443)
NOPBT Margin
Operating Taxes
2,199
63
411
Tax Rate
NOPAT
(179,647)
(146,880)
(111,854)
Net income
40,720
-127.29%
(149,189)
47.39%
(101,219)
279.99%
Dividends
Dividend yield
Proceeds from repurchase of equity
9,067
2,110
7,927
BB yield
-0.34%
-0.16%
-0.32%
Debt
Debt current
16,868
11,006
2,042
Long-term debt
238,896
221,976
157,696
Deferred revenue
9,043
25,598
30,064
Other long-term liabilities
667
800
300
Net debt
(290,490)
(243,788)
(459,908)
Cash flow
Cash from operating activities
(136,733)
(119,683)
(70,669)
CAPEX
(13,403)
(8,014)
(7,167)
Cash from investing activities
193,034
90,023
(16,812)
Cash from financing activities
9,048
2,110
7,952
FCF
(200,524)
(181,697)
(181,994)
Balance
Cash
463,003
451,087
576,479
Long term investments
83,251
25,683
43,167
Excess cash
535,421
467,722
612,749
Stockholders' equity
(337,415)
(380,795)
(229,879)
Invested Capital
1,023,565
971,589
897,197
ROIC
ROCE
EV
Common stock shares outstanding
74,987
71,173
70,595
Price
35.80
91.55%
18.69
-46.34%
34.83
-56.01%
Market cap
2,684,528
101.81%
1,330,231
-45.90%
2,458,822
-48.27%
EV
2,394,038
1,086,454
1,998,928
EBITDA
(171,896)
(142,473)
(108,596)
EV/EBITDA
Interest
3
Interest/NOPBT